American Journal of Kidney Diseases
Volume 48, Issue 2 , Pages 192-204 , August 2006

Identification and Referral of Patients With Progressive CKD: A National Study

  • L. Ebony Boulware, MD, MPH

      Affiliations

    • Corresponding Author InformationAddress reprint requests to L. Ebony Boulware, MD, MPH, Assistant Professor of Medicine and Epidemiology, Welch Center for Prevention, Epidemiology and Clinical Research, Division of General Internal Medicine, Johns Hopkins Medical Institutions, 2024 E Monument St, Ste 2-600, Baltimore, MD 21205
    • ,
  • Misty U. Troll, MPH
    • ,
  • Bernard G. Jaar, MD, MPH
    • ,
  • Donna I. Myers, MD
    • ,
  • Neil R. Powe, MD, MPH, MBA

Received 10 March 2006 ,Accepted 20 April 2006.

References 

  1. Coresh J , Astor BC , Greene T , Eknoyan G , Levey AS . Prevalence of chronic kidney disease and decreased kidney function in the adult US population (Third National Health and Nutrition Examination Survey) . Am J Kidney Dis . 2003;41:1–12
  2. Shlipak MG , Sarnak MJ , Katz R , et al.   Cystatin C and the risk of death and cardiovascular events among elderly persons . N Engl J Med . 2005;352:2049–2060
  3. Sarnak MJ , Katz R , Stehman-Breen CO , et al.   Cystatin C concentration as a risk factor for heart failure in older adults . Ann Intern Med . 2005;142:497–505
  4. Go AS , Chertow GM , Fan D , McCulloch CE , Hsu CY . Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization . N Engl J Med . 2004;351:1296–1305
  5. Agodoa LY , Appel L , Bakris GL , et al.   Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis (A randomized controlled trial) . JAMA . 2001;285:2719–2728
  6. Jafar TH , Stark PC , Schmid CH , et al.   Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease . Kidney Int . 2001;60:1131–1140
  7. Agewall S , Wikstrand J , Ljungman S , Fagerberg B  Risk Factor Intervention Study Group . Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus . Am J Cardiol . 1997;80:164–169
  8. Brancati FL , Whelton PK , Randall BL , Neaton JD , Stamler J , Klag MJ . Risk of end-stage renal disease in diabetes mellitus: A prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial . JAMA . 1997;278:2069–2074
  9. Garg AX , Clark WF , Haynes RB , House AA . Moderate renal insufficiency and the risk of cardiovascular mortality (Results from the NHANES I) . Kidney Int . 2002;61:1486–1494
  10. Ruggenenti P , Perna A , Remuzzi G . ACE inhibitors to prevent end-stage renal disease: When to start and why possibly never to stop: A post hoc analysis of the REIN trial results (Ramipril Efficacy in Nephropathy) . J Am Soc Nephrol . 2001;12:2832–2837
  11. Hansson L , Lindholm LH , Niskanen L , et al.   Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension (The Captopril Prevention Project (CAPPP) randomised trial) . Lancet . 1999;353:611–616
  12. Cleveland DR , Jindal KK , Hirsch DJ , Kiberd BA . Quality of prereferral care in patients with chronic renal insufficiency . Am J Kidney Dis . 2002;40:30–36
  13. Kinchen KS , Sadler J , Fink N , et al.   The timing of specialist evaluation in chronic kidney disease and mortality . Ann Intern Med . 2002;137:479–486
  14. Cass A , Cunningham J , Snelling P , Ayanian JZ . Late referral to a nephrologist reduces access to renal transplantation . Am J Kidney Dis . 2003;42:1043–1049
  15. Levin A , Stevens LA . Executing change in the management of chronic kidney disease (Perspectives on guidelines and practice) . Med Clin North Am . 2005;89:701–709
  16. Nissenson AR , Collins AJ , Hurley J , Petersen H , Pereira BJ , Steinberg EP . Opportunities for improving the care of patients with chronic renal insufficiency (Current practice patterns) . J Am Soc Nephrol . 2001;12:1713–1720
  17. National Kidney Foundation: K/DOQI Clinical Practice Guidelines 2000. Available at: http://www.kidney.org/professionals/doqi/kdoqi/p4_class_g1.htm. Accessed January 18, 2002.
  18. Hostetter TH , Lising M . National kidney disease education program . J Am Soc Nephrol . 2003;14(7 Suppl 2):S114–S116
  19. Levey AS , Bosch JP , Lewis JB , Greene T , Rogers N , Roth D  Modification of Diet in Renal Disease Study Group . A more accurate method to estimate glomerular filtration rate from serum creatinine (A new prediction equation) . Ann Intern Med . 1999;130:461–470
  20. Martinez-Ramirez HR , Jalomo-Martinez B , Cortes-Sanabria L , et al.   Renal function preservation in type 2 diabetes mellitus patients with early nephropathy (A comparative prospective cohort study between primary health care doctors and a nephrologist) . Am J Kidney Dis . 2006;47:78–87
  21. Lea JP , McClellan WM , Melcher C , Gladstone E , Hostetter T . CKD risk factors reported by primary care physicians (Do guidelines make a difference?) . Am J Kidney Dis . 2006;47:72–77
  22. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia) . Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy . Lancet . 1997;349:1857–1863
  23. Brenner BM , Cooper ME , de Zeeuw D , et al.   Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy . N Engl J Med . 2001;345:861–869
  24. Lewis EJ , Hunsicker LG , Clarke WR , et al.   Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes . N Engl J Med . 2001;345:851–860
  25. Kinchen KS , Sadler J , Fink N , et al.   The timing of specialist evaluation in chronic kidney disease and mortality . Ann Intern Med . 2002;137:479–486
  26. Fox CH , Brooks A , Zayas LE , McClellan W , Murray B . Primary care physicians’ knowledge and practice patterns in the treatment of chronic kidney disease (An Upstate New York Practice-based Research Network (UNYNET) study) . J Am Board Fam Med . 2006;19:54–61
  27. Cabana MD , Rand CS , Powe NR , et al.   Why don’t physicians follow clinical practice guidelines? (A framework for improvement) . JAMA . 1999;282:1458–1465
  28. National Kidney Disease Education Program: Health professionals: rationale for use and reporting of estimated GFR. 2006. Available at:http://nkdep.nih.gov/professionals/estimated_gfr.htm. Accessed January 11, 2006.
  29. Kuo D , Gifford DR , Stein MD . Curbside consultation practices and attitudes among primary care physicians and medical subspecialists . JAMA . 1998;280:905–909
  30. Keating NL , Zaslavsky AM , Ayanian JZ . Physicians’ experiences and beliefs regarding informal consultation . JAMA . 1998;280:900–904
  31. Jones C , Roderick P , Harris S , Rogerson M . An evaluation of a shared primary and secondary care nephrology service for managing patients with moderate to advanced CKD . Am J Kidney Dis . 2006;47:103–114
  32. Mendelssohn DC , Barrett BJ , Brownscombe LM , et al.   Elevated levels of serum creatinine (Recommendations for management and referral) . CMAJ . 1999;161:413–417
  33. Snow V , Weiss KB , LeFevre M , et al.   Management of newly detected atrial fibrillation (A clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians) . Ann Intern Med . 2003;139:1009–1017
  34. Gonzales R , Bartlett JG , Besser RE , et al.   Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis (Background) . Ann Emerg Med . 2001;37:720–727
  35. Gonzales R , Bartlett JG , Besser RE , et al.   Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis (Background) . Ann Intern Med . 2001;134:521–529
  36. Snow V , Mottur-Pilson C , Gonzales R . Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults . Ann Intern Med . 2001;134:487–489
  37. Chamany S , Schulkin J , Rose CE , Riley LE , Besser RE . Knowledge, attitudes, and reported practices among obstetrician-gynecologists in the USA regarding antibiotic prescribing for upper respiratory tract infections . Infect Dis Obstet Gynecol . 2005;13:17–24
  38. Choudhry NK , Fletcher RH , Soumerai SB . Systematic review (The relationship between clinical experience and quality of health care) . Ann Intern Med . 2005;142:260–273
  39. Peabody JW , Luck J , Glassman P , Dresselhaus TR , Lee M . Comparison of vignettes, standardized patients, and chart abstraction (A prospective validation study of 3 methods for measuring quality) . JAMA . 2000;283:1715–1722
  40. National Kidney Disease Education Program: Tools and Resources for Health Professionals: GFR Calculators. Available at: http://www.nkdep.nih.gov/. Accessed April 10, 2006.

 Originally published online as doi:10.1053/j.ajkd.2006.04.073 on June 14, 2006.Support: Funding sources are National Kidney Foundation of Maryland Mini-Grant (L.E.B.); Robert Wood Johnson Harold Amos Faculty Development Program (L.E.B.); Grant no. K240502643 from National Institute of Diabetes and Digestive and Kidney Diseases (N.R.P.). Potential conflicts of interest: None.

PII: S0272-6386(06)00765-7

doi: 10.1053/j.ajkd.2006.04.073

American Journal of Kidney Diseases
Volume 48, Issue 2 , Pages 192-204 , August 2006

Article Tools

* Image Usage & Resolution